We are live on ! Find out more
DIM

DC Investments Management Portfolio holdings

AUM $261M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+31.6%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$149M
Cap. Flow
+$114M
Cap. Flow %
41.99%
Top 10 Hldgs %
48.85%
Holding
371
New
126
Increased
44
Reduced
118
Closed
53

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$27.5M
2
AAPL icon
Apple
AAPL
+$25.2M
3
AMZN icon
Amazon
AMZN
+$20.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.42M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$7.78M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$5.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.85M
3
MRK icon
Merck
MRK
+$1.69M
4
PFE icon
Pfizer
PFE
+$961K
5
COP icon
ConocoPhillips
COP
+$895K

Sector Composition

Rank Sector Weight
1 Technology 28.94%
2 Healthcare 19.83%
3 Consumer Discretionary 10.61%
4 Communication Services 9.9%
5 Energy 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PANW icon
26
Palo Alto Networks
PANW
$297B
$1.08M 0.4%
28,218
– –
RPD icon
27
Rapid7
RPD
$773M
$1.08M 0.4%
21,159
– –
NVO
28
Novo Nordisk
NVO
$209B
$1.07M 0.39%
32,772
+708
+2% +$22.6K
MRK icon
29
Merck
MRK
$318B
$1.04M 0.38%
14,163
-22,447
-61% -$1.69M
NVS icon
30
Novartis
NVS
$297B
$1.01M 0.37%
11,599
+1,780
+18% +$154K
NLY icon
31
Annaly Capital Management
NLY
$17.4B
$974K 0.36%
+37,123
New +$917K
MIME
32
DELISTED
Mimecast Limited
MIME
$971K 0.36%
23,309
– –
JNJ icon
33
Johnson & Johnson
JNJ
$625B
$963K 0.35%
6,848
+2,387
+54% +$348K
BDX icon
34
Becton Dickinson
BDX
$48.2B
$950K 0.35%
4,070
+687
+20% +$166K
PHG icon
35
Philips
PHG
$26.1B
$948K 0.35%
24,960
-506
-2% -$17.6K
EBS icon
36
Emergent Biosolutions
EBS
$248M
$866K 0.32%
+10,945
New +$816K
LLY icon
37
Eli Lilly
LLY
$1.06T
$851K 0.31%
5,186
+66
+1% +$10.1K
CTXS
38
DELISTED
Citrix Systems Inc
CTXS
$838K 0.31%
5,668
-215
-4% -$30.9K
JKHY icon
39
Jack Henry & Associates
JKHY
$11.1B
$817K 0.3%
4,438
+196
+5% +$34.2K
WST icon
40
West Pharmaceutical
WST
$24.9B
$807K 0.3%
3,552
+1,742
+96% +$342K
ACN icon
41
Accenture
ACN
$108B
$740K 0.27%
3,445
-1,376
-29% -$260K
AMGN icon
42
Amgen
AMGN
$222B
$738K 0.27%
3,130
+1,038
+50% +$237K
ZTS icon
43
Zoetis
ZTS
$30B
$732K 0.27%
5,339
+68
+1% +$8.88K
STE icon
44
Steris
STE
$23.1B
$727K 0.27%
4,735
-1,910
-29% -$291K
CHE icon
45
Chemed
CHE
$7.22B
$715K 0.26%
1,586
-32
-2% -$14.3K
COST icon
46
Costco
COST
$420B
$710K 0.26%
2,340
+1,459
+166% +$444K
ABT icon
47
Abbott
ABT
$187B
$705K 0.26%
7,714
+222
+3% +$20.1K
TMUS icon
48
T-Mobile US
TMUS
$190B
$705K 0.26%
6,768
+3,256
+93% +$312K
BAX icon
49
Baxter International
BAX
$14.2B
$703K 0.26%
8,163
+2,512
+44% +$219K
SLGN icon
50
Silgan Holdings
SLGN
$4.41B
$702K 0.26%
21,676
+1,578
+8% +$51.4K
1
2
3 4 5

Similar funds

DC
Dayah Capital Stamford, Connecticut $261M AUM
TIG
Tribune Investment Group New York $261M AUM 70.13% 1-Year Est. Return
NG
NWK Group San Francisco, California $261M AUM 50.13% 1-Year Est. Return
ICM
Intrepid Capital Management Jacksonville Beach, Florida $261M AUM 20.02% 1-Year Est. Return
TSW
Three Seasons Wealth Salt Lake City, Utah $262M AUM 45.03% 1-Year Est. Return
ACM
Ananym Capital Management New York $262M AUM 22.94% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
LB
Legacy Bridge West Des Moines, Iowa $262M AUM 56.69% 1-Year Est. Return

DC Investments Management's Q2 2020 Portfolio in Review

As of Q2 2020, DC Investments Management held 371 positions worth $272M, up 121% from $123M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

DC Investments Management deployed $114M of net new capital in Q2 2020, opening 126 new positions and adding to 44 existing holdings. Its largest new stake was Microsoft: 151,331 shares worth $30.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $5.2M trimmed.

  • DC Investments Management's largest Q2 2020 buy was Microsoft: 151,331 shares worth $30.8M.
  • DC Investments Management added most to Amazon in Q2 2020, an estimated $20.1M increase.
  • DC Investments Management's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $5.2M.
  • DC Investments Management fully exited Forty Seven, Inc. Common Stock in Q2 2020, selling an estimated $767K.
  • DC Investments Management's ten largest holdings make up 49% of its $272M portfolio in Q2 2020.
  • DC Investments Management opened 126 new positions and closed 53 in Q2 2020.
  • DC Investments Management's portfolio value rose 121% quarter-over-quarter to $272M.

Based on DC Investments Management's 13F filing for Q2 2020, filed 3 Aug 2020.